COMMUNIQUÉS West-GlobeNewswire

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
02/01/2025
ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
02/01/2025
FOSTER CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
02/01/2025
SEATTLE, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference
02/01/2025
MENLO PARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 43rd [...]
Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
02/01/2025
REDWOOD CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be [...]
Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
02/01/2025
PARSIPPANY, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 43 r d Annual J.P. Morgan Healthcare Conference at 10:30 AM PT (1:30 PM EST) on [...]
EssilorLuxottica strengthens its presence in the hearing space with the acquisition of an AI-driven tech startup in France
02/01/2025
EssilorLuxottica strengthens its presence in the hearing space with the acquisition of an AI-driven tech startup in France Pulse Audition features technology that can embed AI-based speech enhancement into glasses Paris [...]
EssilorLuxottica se renforce dans le domaine de l'audition avec l'acquisition d'une startup technologique française centrée sur l'IA
02/01/2025
EssilorLuxottica se renforce dans le domaine de l'audition avec l'acquisition d'une startup technologique française centrée sur l'IA Pulse Audition apporte une technologie d'Intelligence Artificielle permettant d’ [...]
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
02/01/2025
-If approved, deramiocel would be first approved therapy for Duchenne muscular dystrophy cardiomyopathy- -BLA submission triggers $10 million milestone payment to Capricor from Nippon Shinyaku- SAN DIEGO, Jan. 02, 2025 [...]
NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer
02/01/2025
LANGHORNE, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain
02/01/2025
IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approval SP-26 ketamine implants nearing first animal studies SARASOTA, FL, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Silo [...]
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
02/01/2025
PITTSBURGH, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced that it [...]
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
02/01/2025
DURHAM, N.C., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has successfully completed the [...]
Lexicon Appoints Scott Coiante as Chief Financial Officer
02/01/2025
THE WOODLANDS, Texas, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the appointment of Scott Coiante as senior vice president and chief financial officer, effective today [...]
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
02/01/2025
FREMONT, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 43 rd Annual J.P. [...]
GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing
02/01/2025
Company today announced a major strategic step forward as it explores new growth avenues Artificial Intelligence (AI) and Quantum Computing industries represent multi-trillion dollar market opportunities 1,2 Company is [...]
SELLAS to Host Corporate Update Call on January 8, 2025, at 9:00 am ET
02/01/2025
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a [...]
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
02/01/2025
SOUTH SAN FRANCISCO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present at [...]
Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office
02/01/2025
Vancouver, Canada, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

Pages